Antigens from Leishmania amastigotes induced clinical remission of psoriasis

Archives of Dermatological Research

Volumn 301, Issue 1, 2009, Pages 1-13

  O'Daly, J A ^a,b,c   Lezama, R ^b   Rodriguez, P J ^b   Silva, E ^b   Indriago, N R ^b   Pena G ^a   Colorado, I ^a   Gleason, J ^a   Rodriguez B ^c   Acuna L ^c   Ovalles, T ^c  

^a Astralis LTD   (United States)

^b Center for Psoriasis Research and Treatment   (Venezuela)

^c INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

Amastigote antigens; Clinical trial; Immunotherapy; Leishmaniasis; Psoriasis

Indexed keywords

AS100 ANTIGEN; LEISHMANIA VACCINE; PLACEBO; UNCLASSIFIED DRUG;

ACCIDENTAL INJURY; ADOLESCENT; ADULT; AMASTIGOTE; ARTHRALGIA; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLU LIKE SYNDROME; HEADACHE; HUMAN; HUMORAL IMMUNITY; INJECTION SITE ERYTHEMA; INJECTION SITE NODULE; INJECTION SITE PAIN; INJECTION SITE REACTION; LEISHMANIA; LEISHMANIASIS; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; PRURITUS; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; REMISSION; SOMNOLENCE; T LYMPHOCYTE; TONSILLITIS; TREATMENT OUTCOME; URINARY TRACT INFECTION; VOMITING; WEAKNESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ANTIGENS, SURFACE; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-GAMMA; LEISHMANIA; LEISHMANIASIS VACCINES; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; PSORIASIS; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES;

EID: 58149143133     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-008-0883-9     Document Type: Article

References (29)

1. Christophers E, Mrowietz U (2003) Psoriasis. In: Freedberg IM, Eisen AZ, Wolff KK, Austen F, Goldsmith LA, Katz SI (eds) Fitzpatrick's dermatology in general medicine, 6th edn. McGraw-Hill, New York, pp 407-427
2. EM Farber ML Nall 1974 The natural history of psoriasis in 5,600 patients Dermatologica 148 1 18
3. JE Gudjonsson A Johnston H Sigmundsdottir H Valdimarsson 2004 Immunopathogenic mechanisms in psoriasis Clin Exp Immunol 135 1 8
4. F Wang W Lew JG Krueger 2004 The therapy of psoriasis based on innate and adaptive immune mechanisms of disease pathogenesis G Ital Dermatol Venereol 139 207 230
5. LF Santamaria Babi R Moser MT Perez Soler 1995 Migration of skin-homing T cell across cytokine activated human endothelial cell layers involves interaction of the cutaneous lymphocyte-associated antigen (CLA) the very late antigen 4 (VLA-4) and the lymphocyte function-associated antigen-1 (LFA-1) J Immunol 154 1543 1550
6. U Mrowietz JT Elder J Barke 2007 The importance of disease associations and concomitant therapy for the long term management of psoriasis patients Arch Dermatol Res 298 309 319
7. A Nast I Koop M Augustin 2007 German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version) Arch Dermatol Res 299 111 138
8. World Health Organization. Leishmaniasis Control Home Page. http: www.who.int/ctd/html/leis.html. Related articles recently published in Archives of Dermatological Research (selected by the journal's editorial staff)
9. E Handman 2001 Leishmaniasis: current status of vaccine development Clin Microbiol Rev 14 229 243
10. A Schubach AB Oliveira T Cuzzi-Maya 1988 Cicatricial lesions of Cutaneous leishmaniasis (CL) detection of Leishmania brasiliensis brasiliensis (L.b.b.) antigens by the immunoperoxidase avidin and biotin technique IP-AB Mem Inst Oswaldo Cruz 83 129 134
11. ML Fernandez-Guerrero JM Aguado C Barros 1987 Visceral leishmaniasis in immunocompromised hosts Am J Med 83 1098 1102
12. J Rodriguez Coura B Galvao-Castro G Grimaldi 1987 Disseminated American cutaneous leishmaniasis in a patient with AIDS Mem Inst Oswaldo Cruz 82 581 582
13. NS Sadick NS McNutt MH Kaplan 1990 Papulosquamous dermatoses of AIDS J Am Acad Dermatol 22 1270 1277
14. JA O'Daly H Spinetti MB Rodríguez 1995 Proteínas de amastigotes de varias cepas de leishmanias protegen a seres humanos contra la Leishmaniasis en el área de Guatire, Edo. Miranda, Venezuela Gac Méd Caracas 103 133 177
15. JA O'Daly H Spinetti MB Rodríguez 1995 Comparación de los efectos terapéuticos de la mezcla de promastigotes + BCG, antígenos purificados de amastigotes y el Glucantime en un área hiperendémica de Leishmaniasis cutánea, en Guatire, Edo, Miranda, Venezuela Gac Méd Caracas 103 327 357
16. M Kemp MB Hansen TG Theander 1992 Recognition of leishmania antigens by T lymphocytes from nonexposed individuals Infect Immun 60 2246 2251
17. JA O'Daly MB Rodríguez 1988 Differential growth requirement of several Leishmania spp in chemically defined culture media Acta Trop (Basel) 45 109 126
18. JA O'Daly L Serrano MB Rodríguez 1983 Free amino-acid pool and proteolytic enzymes in Trypanosoma cruzi, cultured in vitro Int J Parasitol 13 433 440
19. JA O'Daly Z Cabrera 1986 Immunization of hamsters with TLCK-killed parasites induce protection against Leishmania infection Acta Trop 43 225 236
20. JA O'Daly N Polanco 1990 Variability of Trypanosoma cruzi epimastigote surface antigens with changes in the temperature of the cultures Am J Trop Med Hyg 43 44 51
21. OH Lowry NJ Rosebrough AL Farr RJ Randall 1951 Protein measurement with the folin phenol reagent J Biol Chem 193 1 265 275
22. PK Smith RI Krohn GT Hermanson 1985 Measurement of protein using bicinchoninic acid Anal Biochem 150 76 85
23. T Fredriksson U Pettersson 1978 Severe psoriasis-oral therapy with a new retinoid Dermatologica 157 238 244
24. JA O'Daly H Carrasco V Fernández MB Rodríguez 1994 A study of Chagasic and non-chagasic miocardiopathies by ELISA and immunoblotting with Trypanosoma cruzi and Trypanosoma rangeli antigens Acta Trop 56 265 287
25. SF Brenière J Telleria MF Bosseno 1999 Polymerase chain reaction-based identification of new world Leishmania species complexes by specific kDNA probes Acta Trop 73 283 289
26. JE Sokal 1975 Measurement of delayed skin test responses N Engl J Med 293 501 502
27. M Seifert W Sterry E Effenberger 2000 The antipsoriatic activity of IL-10 is rather caused by effects on peripheral blood cells than by a direct effect on human keratinocytes Arch Dermatol Res 292 64 72
28. SP Jariwala 2007 The role of dendritic cells in the immunopathogenesis of psoriasis Arch Dermatol Res 299 359 366
29. KA Papp 2006 The long-term efficacy and safety of new biological therapies for psoriasis Arch Dermatol Res 298 7 15